Anglo American plc (LON:AAL)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	23,439	28,685	23,903	39,296	36,713	29,920
Market Cap Growth	-23.51%	20.01%	-39.17%	7.03%	22.71%	11.63%
Enterprise Value	34,455	42,606	36,345	48,296	44,022	40,958
Last Close Price	21.72	23.14	18.69	29.34	25.43	18.86
PE Ratio	-	-	107.58	10.49	5.81	19.56
Forward PE	24.24	15.46	10.80	8.87	7.47	10.59
PS Ratio	1.20	1.32	0.99	1.35	1.20	1.61
PB Ratio	1.26	1.26	0.96	1.39	1.43	1.25
P/TBV Ratio	1.74	1.81	1.29	1.93	2.00	1.80
P/FCF Ratio	23.10	13.97	49.11	13.25	4.52	20.73
P/OCF Ratio	5.05	4.43	4.69	4.85	2.97	6.17
PEG Ratio	5.28	0.39	3.07	-	0.46	0.81
EV/Sales Ratio	1.77	1.96	1.51	1.66	1.43	2.20
EV/EBITDA Ratio	6.32	7.01	5.35	4.36	3.02	6.19
EV/EBIT Ratio	10.88	10.83	7.39	5.34	3.44	8.46
EV/FCF Ratio	33.96	20.75	74.67	16.28	5.42	28.37
Debt / Equity Ratio	0.66	0.67	0.56	0.42	0.37	0.41
Debt / EBITDA Ratio	2.32	2.37	1.96	1.08	0.65	1.47
Debt / FCF Ratio	12.22	7.38	28.33	4.02	1.18	6.87
Asset Turnover	0.42	0.42	0.46	0.53	0.65	0.43
Inventory Turnover	2.42	1.92	2.04	4.07	2.37	1.85
Quick Ratio	1.65	1.24	1.12	1.25	1.24	1.21
Current Ratio	2.72	2.13	1.85	1.90	1.79	1.93
Return on Equity (ROE)	-4.27%	-9.27%	4.10%	17.53%	34.64%	10.38%
Return on Assets (ROA)	4.16%	4.68%	5.84%	10.21%	16.84%	6.96%
Return on Capital (ROIC)	5.63%	6.37%	8.03%	14.18%	23.02%	9.34%
Return on Capital Employed (ROCE)	8.30%	8.90%	10.90%	19.10%	31.30%	12.40%
Earnings Yield	-13.31%	-8.54%	0.93%	9.53%	17.22%	5.11%
FCF Yield	4.33%	7.16%	2.04%	7.55%	22.11%	4.83%
Dividend Yield	2.53%	2.51%	4.58%	6.36%	9.53%	4.41%
Payout Ratio	-	-	552.65%	65.06%	35.59%	43.27%
Buyback Yield / Dilution	-5.75%	0.66%	0.49%	2.00%	0.16%	2.41%
Total Shareholder Return	-3.22%	3.16%	5.07%	8.36%	9.69%	6.82%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.